These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 5626124)
41. Using human growth hormone (somatropin). Drug Ther Bull; 1989 Dec; 27(25):97-8. PubMed ID: 2519321 [No Abstract] [Full Text] [Related]
42. The problem of short stature in childhood: growth hormone deficiency and its treatment with human growth hormone. Soyka LF Med Times; 1966 Jan; 94(1):1-8. PubMed ID: 5321617 [No Abstract] [Full Text] [Related]
43. [Electroencephalographic studies in hypophyseal dwarfism in childhood]. Lässker G; Degen R Kinderarztl Prax; 1971 Aug; 39(8):368-74. PubMed ID: 4332908 [No Abstract] [Full Text] [Related]
44. Effectiveness of Soviet-produced human somatotropin in the treatment of hypothalamo-pituitary dwarfism. Lashene DG Neurosci Behav Physiol; 1983; 13(2):126-9. PubMed ID: 6657043 [No Abstract] [Full Text] [Related]
45. [Therapeutic results in correction of defects of height growth. Preliminary note]. Prosperi P; Cimmarrusti F Minerva Pediatr; 1965 Aug; 17(23):1228-30. PubMed ID: 5851480 [No Abstract] [Full Text] [Related]
46. Hypothalamic-pituitary function in Chinese and idiopathic hypothalamo-pituitary dwarfism. Lin CY Taiwan Yi Xue Hui Za Zhi; 1987 Jan; 86(1):52-7. PubMed ID: 3106560 [No Abstract] [Full Text] [Related]
47. [Results of treatment with human growth hormone in childhood]. Job JC Bull Acad Natl Med; 1984; 168(5-6):543-7. PubMed ID: 6440663 [No Abstract] [Full Text] [Related]
48. Growth hormone therapy effective in treatment of variety of hormone deficiency disorders in children. Prakasam G Manag Care Interface; 2005; Suppl():3-5. PubMed ID: 16268195 [No Abstract] [Full Text] [Related]
49. Point of view: therapy with growth hormone. Page LA; Orson JM R I Med; 1995 Nov; 78(11):326. PubMed ID: 8547725 [No Abstract] [Full Text] [Related]
50. [Preliminary results in the treatment of pituitary dwarfism with human growth hormone]. Eisner M; Derech K; Prochorow M Przegl Lek; 1968; 24(10):768-72. PubMed ID: 5711467 [No Abstract] [Full Text] [Related]
51. Pituitary dwarfism in a patient with circulating abnormal growth hormone polymers. Valenta LJ; Sigel MB; Lesniak MA; Elias AN; Lewis UJ; Friesen HG; Kershnar AK N Engl J Med; 1985 Jan; 312(4):214-7. PubMed ID: 3965948 [No Abstract] [Full Text] [Related]
52. [Studies on the effect of human growth hormone on metabolism in hypophyseal and hypothyroid dwarfism]. Seige K; Ulrich E Z Alternsforsch; 1965 Nov; 18(3):302-10. PubMed ID: 5875434 [No Abstract] [Full Text] [Related]
53. [Therapeutic use of thyreotropin releasing hormone in hypophyseal dwarfism with secondary hypothyreosis]. Stolecke H Monatsschr Kinderheilkd (1902); 1974 Jul; 122(7):607-9. PubMed ID: 4212865 [No Abstract] [Full Text] [Related]
58. [Therapy in dwarfism. Use of genetically produced growth hormone in practice]. Neugebauer M Med Monatsschr Pharm; 1986 Nov; 9(11):345-6. PubMed ID: 3543630 [No Abstract] [Full Text] [Related]
59. [Pituitary dwarfism due to peripheral resistance to somatotropic hormone]. Boscherini B Minerva Pediatr; 1976 May; 28(18):1093-4. PubMed ID: 1012183 [No Abstract] [Full Text] [Related]
60. [Diagnostic and therapeutic rules for hypothalamic-pituitary dwarfism]. Hinkel GK; Hesse V; Keller E; Otto FM; Verron G; Willgerodt H Kinderarztl Prax; 1978 May; 46(5):265-71. PubMed ID: 556487 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]